EEA bilateral initiatives at the Faculty of Medicine MU: one successfully finishing, another kicking-off
Researchers from the Department of Pharmacology and their collaborators at the University of Bergen, Norway, started a fruitful collaboration a couple of years back thanks to a project of bilateral initiative from the EEA and Norwegian funds. The project intended to boost collaboration by supporting mobility and knowledge transfer started in the fall of 2020.
The main Norwegian partner, prof. Silje Skrede describes: “One day, I just got an e-mail proposing a collaboration on a topic close to my heart, metabolic disturbances induced by antipsychotic medications. I naturally could not resist, we drafted together an EEA project to cover my participation and very soon we had up and running pilot study. And then covid struck.” Despite all efforts, the mobilities were simply impossible for quite a long time and the project seemed to be stuck. However, as the Czech principal investigator assoc. prof. Jana Ruda continues: “We had 60 rats in the lab and our partner skilled in a key technique could not come. So, we shared some videos, read a couple of protocols and finally set up a video call directly from the animal house. And thanks to the efforts of all of us, it worked.” Several hundreds of samples were collected and analyzed during the lockdown. “I could not imagine this collaboration could be this efficient. We proposed several research projects together, have a long publication plan and plan to move it up to the clinical research field, which I always wanted.” Claims a key collaborator on the project dr. Katerina Horska (Faculty of Pharmacy MU), who dedicated her whole research career to this topic.
With the help of the EEA bilateral initiative, so far, one review paper was published, one original paper submitted, and another will be submitted by the end of this summer. Regular mobilities Brno – Bergen and back are being held and now, the collaboration is at a point of a new beginning. Another bilateral project was awarded to the same team and this collaboration will be extended to more research teams within prof. Skrede’s professional network. “We are really enthusiastic about the follow-up project. Currently, we are planning another experiment and we sincerely hope that this one will go as planned. We could use some uneventful time.” smiles assoc. prof. Ruda.
The budget of both projects combined is as high as 920 thousand CZK and the costs are mainly covering the mobility of the team members. So far, five researchers from MU visited Bergen (three of them twice) and prof. Skrede was welcome in Brno three times. The follow-up project will last till the summer 2024.
Projects Pharmacological reversal of metabolic derrangements induced by antipsychotic treatment in animal models and Pharmacological reversal of metabolic derangements induced by antipsychotic treatment in animal models: intensification of the collaboration is financed from Fund for Bilateral Relations within the framework of the EEA and Norway Grants 2014-2021.
Contact for media:
Assoc. Prof. PharmDr. Jana Rudá, Ph.D., Farmakologický ústav LF MU, +420 549 49 4238,
Ing. Barbora Ježková, Oddělení projektové podpory, +420 549 49 8325, email@example.com
Mgr. Václav Tesař, Oddělení pro komunikaci a vnější vztahy LF MU, +420 733 553 215, firstname.lastname@example.org
|Download Article||.pdf 121 kB|
|Download Photos||.zip 2,557 kB|
More press releases
Prestigious grant HORIZON EUROPE - “BEATsep” will tackle long-term consequences of sepsis.
The research consortium BEATsep, established by the Cellular and Molecular Immunoregulation (CMI) research team at the International Clinical Research Centre (ICRC), has been awarded a 6.9 million euro HORIZON EUROPE grant. The project entitled “Biomarkers established to stratify sepsis long-term adverse effects to improve patients’ health and quality of life (BEATsep) aims to define markers of poor recovery of patients after sepsis and septic shock. This will be achieved through the discovery of novel mechanisms and their markers predicting the decline of health-related quality of life after sepsis. Sepsis and septic shock, affecting up to 50 million people worldwide with mortality reaching 20%, leaves large cohorts of vulnerable patients suffering from long-term complications that affect their quality of life.
How fast do teeth and bones grow? A new method can quantify this, opening up further possibilities for tissue engineering
How fast teeth grow, what influences their growth dynamics and how dental tissues regenerate. All this can be monitored in detail by a new monitoring method developed by the research group of Assoc. Mgr. Jan Křivánek, Ph.D.